- Home
- PBF vs RYTM Comparison
PBF vs RYTM Comparison
Compare PBF & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBF
- RYTM
- Stock Information
- Founded
- PBF 2008
- RYTM 2008
- Country
- PBF United States
- RYTM United States
- Employees
- PBF N/A
- RYTM N/A
- Industry
- PBF Integrated oil Companies
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- PBF Energy
- RYTM Health Care
- Exchange
- PBF Nasdaq
- RYTM Nasdaq
- Market Cap
- PBF 3.4B
- RYTM 3.1B
- IPO Year
- PBF 2012
- RYTM 2017
- Fundamental
- Price
- PBF $27.82
- RYTM $56.14
- Analyst Decision
- PBF Hold
- RYTM Strong Buy
- Analyst Count
- PBF 12
- RYTM 10
- Target Price
- PBF $33.09
- RYTM $63.70
- AVG Volume (30 Days)
- PBF 1.7M
- RYTM 470.5K
- Earning Date
- PBF 02-13-2025
- RYTM 11-05-2024
- Dividend Yield
- PBF 3.98%
- RYTM N/A
- EPS Growth
- PBF N/A
- RYTM N/A
- EPS
- PBF N/A
- RYTM N/A
- Revenue
- PBF $34,902,700,000.00
- RYTM $112,530,000.00
- Revenue This Year
- PBF N/A
- RYTM $63.64
- Revenue Next Year
- PBF N/A
- RYTM $42.98
- P/E Ratio
- PBF N/A
- RYTM N/A
- Revenue Growth
- PBF N/A
- RYTM 81.55
- 52 Week Low
- PBF $27.28
- RYTM $35.17
- 52 Week High
- PBF $62.88
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- PBF 29.24
- RYTM 45.40
- Support Level
- PBF $27.27
- RYTM $54.52
- Resistance Level
- PBF $31.42
- RYTM $58.56
- Average True Range (ATR)
- PBF 1.10
- RYTM 1.90
- MACD
- PBF -0.41
- RYTM -0.65
- Stochastic Oscillator
- PBF 3.37
- RYTM 21.10
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.